Jamie Kwasnieski, Ph.D.
About Jamie Kwasnieski, Ph.D.
Jamie Kwasnieski, Ph.D., is the Head of Platform at Dyno Therapeutics in Watertown, Massachusetts, with extensive experience in molecular biology, genetics, and computational biology.
Company
Jamie Kwasnieski, Ph.D., is currently employed at Dyno Therapeutics in Watertown, Massachusetts, United States. Dyno Therapeutics focuses on gene therapy and AAV (Adeno-Associated Virus) vector engineering.
Title
Jamie Kwasnieski holds the position of Head of Platform at Dyno Therapeutics. Previously, she has served in various capacities including Head of Applied Biology, Principal Scientist, AAV Engineering, Platform Team Lead, and Senior Scientist, AAV Engineering, Platform Team Lead.
Education and Expertise
Jamie Kwasnieski earned her Doctor of Philosophy (Ph.D.) in Molecular Genetics and Genomics from Washington University in St. Louis. She pursued a Bachelor of Arts (B.A.) in Chemistry from Northwestern University. She possesses expertise in molecular biology, genetics, and computational biology. Her academic work includes developing a high-throughput multiplexed reporter assay to understand the grammar of regulatory DNA sequences.
Professional Background
Jamie Kwasnieski has extensive experience in the biotechnology sector. Before her current role, she held various positions at Dyno Therapeutics and was a Postdoctoral Fellow at the Whitehead Institute, where she also chaired the Postdoc Association. Additionally, she has worked as a Project Manager and Consultant at The BALSA Group and as a Student Consultant Supervisor at Northwestern University’s IT Support Center.
Achievements
Notable accomplishments include her development of a high-throughput multiplexed reporter assay during her Ph.D. and her research on the dynamics of RNA during early development while at MIT. Her passion for sharing research is marked by her strong written and verbal communication skills.